ZYKADIA (ceritinib)
150 mg/1 · Film-Coated Tablet
By Novartis Pharmaceuticals Corporation
- NDC
- 0078-0694
- Route
- Oral
- Therapeutic class
- Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], Kinase Inhibitor , Tyrosine Kinase Inhibitors [MoA]
- Marketing category
- NDA
Package sizes
- 21 TABLET, FILM COATED in 1 BOTTLE (0078-0694-48)NDC 0078-0694-48Available to order
- 84 TABLET, FILM COATED in 1 BOTTLE (0078-0694-84)NDC 0078-0694-84Available to order
Additional information
Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.
Request this medication
Send a request and we'll respond with availability, lot details, and pricing within 2 business hours.
Related in Oncology & Specialty
See all →Verzenio (abemaciclib)
50 mg/1 · Tablet
Eli Lilly and Company
Available to source
Verzenio (abemaciclib)
200 mg/1 · Tablet
Eli Lilly and Company
Available to source
Verzenio (abemaciclib)
100 mg/1 · Tablet
Eli Lilly and Company
Available to source
Verzenio (abemaciclib)
150 mg/1 · Tablet
Eli Lilly and Company
Available to source
